Sectoral Asset Management Inc Buys Exelixis Inc, Seattle Genetics Inc, Deciphera Pharmaceuticals Inc, Sells Portola Pharmaceuticals Inc, Stemline Therapeutics Inc, Vocera Communications Inc

• New Purchases: EXEL, DCPH, ABBV, MRTX, TPTX, REGN, RCUS, PFE, GH, MRNA, CRSP,
• Added Positions: SGEN, SRPT, ACAD, QURE, CHNG, SILK, BIIB, GILD, IMMU, HMSY, AZN, INCY, GBT,
• Reduced Positions: VCRA, TDOC, ATRC, TNDM, AERI, INSP, COLL, EVH, FOLD, LLY, BMRN, IRTC, RCM, CI, APLS, TFX, CSII, BSX, BMY, ASMB, MDT, TRHC, NXTC, PTCT, RETA, FGEN, ALNY, MRK, MTEM, HRC, MGTX, AMGN, UNH, ILMN, RDY, ABT, FIXX,
• Sold Out: PTLA, STML, ZBH, TMO, BPMC, ALXN, EVLO, VCEL, AGIO, PHAS, SAGE, UMRX,

For the details of Sectoral Asset Management Inc's stock buys and sells, go to https://www.gurufocus.com/guru/sectoral+asset+management+inc/current-portfolio/portfolio

1. Teladoc Health Inc (TDOC) - 175,875 shares, 5.90% of the total portfolio. Shares reduced by 41.12%
2. Biomarin Pharmaceutical Inc (BMRN) - 184,011 shares, 3.37% of the total portfolio. Shares reduced by 17.82%
3. Boston Scientific Corp (BSX) - 474,334 shares, 3.35% of the total portfolio. Shares reduced by 8.5%
4. Amicus Therapeutics Inc (FOLD) - 1,557,961 shares, 3.12% of the total portfolio. Shares reduced by 24.37%
5. PTC Therapeutics Inc (PTCT) - 298,844 shares, 2.89% of the total portfolio. Shares reduced by 9.09%

Sectoral Asset Management Inc initiated holding in Exelixis Inc. The purchase prices were between $14.46 and $21.8, with an estimated average price of $18.34. The stock is now traded at around $27.01. The impact to a portfolio due to this purchase was 2.64%. The holding were 708,090 shares as of .

Sectoral Asset Management Inc initiated holding in Deciphera Pharmaceuticals Inc. The purchase prices were between $33.63 and $69.4, with an estimated average price of $55.84. The stock is now traded at around $51.05. The impact to a portfolio due to this purchase was 1.82%. The holding were 204,059 shares as of .

Sectoral Asset Management Inc initiated holding in AbbVie Inc. The purchase prices were between $64.5 and $97.79, with an estimated average price of $85.41. The stock is now traded at around $90.43. The impact to a portfolio due to this purchase was 1.38%. The holding were 83,750 shares as of .

Sectoral Asset Management Inc initiated holding in Mirati Therapeutics Inc. The purchase prices were between $69.78 and $128.86, with an estimated average price of $90.44. The stock is now traded at around $107.71. The impact to a portfolio due to this purchase was 1.23%. The holding were 74,100 shares as of .

Sectoral Asset Management Inc initiated holding in Turning Point Therapeutics Inc. The purchase prices were between $32.02 and $66.17, with an estimated average price of $53.48. The stock is now traded at around $55.79. The impact to a portfolio due to this purchase was 1.14%. The holding were 117,800 shares as of .

Sectoral Asset Management Inc initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $336.18 and $494.43, with an estimated average price of $411.31. The stock is now traded at around $579.49. The impact to a portfolio due to this purchase was 0.82%. The holding were 7,770 shares as of .

Sectoral Asset Management Inc added to a holding in Seattle Genetics Inc by 613.33%. The purchase prices were between $95.75 and $119.97, with an estimated average price of $110.87. The stock is now traded at around $162.53. The impact to a portfolio due to this purchase was 2.3%. The holding were 107,000 shares as of .

Sectoral Asset Management Inc added to a holding in Sarepta Therapeutics Inc by 123.32%. The purchase prices were between $82.38 and $131.64, with an estimated average price of $114.91. The stock is now traded at around $132.96. The impact to a portfolio due to this purchase was 1.48%. The holding were 126,759 shares as of .

Sectoral Asset Management Inc added to a holding in ACADIA Pharmaceuticals Inc by 64.38%. The purchase prices were between $31.65 and $46.87, with an estimated average price of $41.34. The stock is now traded at around $48.25. The impact to a portfolio due to this purchase was 0.85%. The holding were 237,450 shares as of .

Sectoral Asset Management Inc added to a holding in uniQure NV by 86.74%. The purchase prices were between $40.01 and $73.97, with an estimated average price of $57.92. The stock is now traded at around $59.68. The impact to a portfolio due to this purchase was 0.78%. The holding were 163,400 shares as of .

Sectoral Asset Management Inc added to a holding in Change Healthcare Inc by 78.40%. The purchase prices were between $6.86 and $17.26, with an estimated average price of $14.09. The stock is now traded at around $10.60. The impact to a portfolio due to this purchase was 0.62%. The holding were 646,895 shares as of .

Sectoral Asset Management Inc added to a holding in Silk Road Medical Inc by 28.91%. The purchase prices were between $23.16 and $47.8, with an estimated average price of $40.19. The stock is now traded at around $34.31. The impact to a portfolio due to this purchase was 0.34%. The holding were 219,400 shares as of .

Sectoral Asset Management Inc sold out a holding in Portola Pharmaceuticals Inc. The sale prices were between $5.78 and $24.74, with an estimated average price of $12.7.

Sectoral Asset Management Inc sold out a holding in Stemline Therapeutics Inc. The sale prices were between $3.41 and $10.79, with an estimated average price of $6.56.

Sectoral Asset Management Inc sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $80.63 and $160.4, with an estimated average price of $135.85.

Sectoral Asset Management Inc sold out a holding in Thermo Fisher Scientific Inc. The sale prices were between $255.3 and $340.05, with an estimated average price of $316.21.

Sectoral Asset Management Inc sold out a holding in Blueprint Medicines Corp. The sale prices were between $48.11 and $82.22, with an estimated average price of $64.89.

Sectoral Asset Management Inc sold out a holding in Alexion Pharmaceuticals Inc. The sale prices were between $75.56 and $113.92, with an estimated average price of $98.6.